A Multicenter, Open label, Phase III Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies that Include Pembrolizumab

9909MK-3475-587Open (affiliates only)A Multicenter, Open label, Phase III Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies that Include Pembrolizumab587-01NCT03486873IndustrialAdultTreatmentIII (Cancer Control)YMultiple - inactiveGibney, GeoffreyGeorgetown University Medical Center : Beth Mekonen; Lombardi Comprehensive Cancer Center : Beth MekonenGenito-urinaryOncology GroupLombardi Comprehensive Cancer Center (LCCC); Oncology PFS16061Beth MekonenBeth Mekonenbam159@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>